TGA Approval

VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial (335256)

ARTG ID

335256

ARTG Name

VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial

Sponsor

Lundbeck Australia Pty Ltd

ARTG Date

June 16, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

LUNDBECK AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/f85c018f85d9a3d059f48fb47f0218e4.pdf

https://medical-cdn.nocode.com/drug_tga/ce14b940fca0ae4fc0c7ba2ebc546316.pdf

Ingredient Name

eptinezumab

Empowering clinical research with data-driven insights and AI-powered tools.

VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial (335256) - TGA 批准文号 | MedPath